Cardiac metabolomics is a cutting-edge field of study that focuses on the comprehensive analysis of small molecules involved in the metabolic processes within the heart. This discipline plays a crucial role in unraveling the intricate interplay of metabolites, providing valuable insights into the metabolic pathways associated with cardiovascular health and disease. By examining the dynamic changes in metabolite profiles, researchers gain a deeper understanding of the molecular mechanisms underlying cardiac conditions, paving the way for the development of innovative diagnostic tools and targeted therapeutic interventions. Through the lens of metabolomics, scientists aim to decipher the metabolic signatures associated with various cardiac disorders, offering a promising avenue for advancing personalized medicine and enhancing our ability to detect, monitor, and treat cardiovascular diseases with greater precision.
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation